Regulatory

THINK Surgical and Ortho Development gained FDA clearance for use of the Balanced Knee System and BKS TriMax Implants with the TSolution One Total Knee Application Active Robot.

Identity Imprint is designed to match patients' anatomy while offering efficiency, cost savings, intraoperative flexibility and faster delivery.

XPERIENCE residual solution remains in the surgical site after closure and continues to help defend against pathogens for several hours.

With FDA clearance for patient-specific instrumentation, Conformis achieved its 3rd milestone and will receive $11 million from Stryker.

This approval is part of the distribution agreement with KICo to market MADISON in the U.S. and Australia.

Catalyst can now address stemless anatomic and reverse TSA, the two fastest growing segments of the shoulder replacement market.

The notice relates to a higher than expected risk of fracture in the device's plastic component, as early as 3 to 4 years post-implantation.

iTotal PS patient-specific implants fit the size and shape of each patient's knee, and provide stability throughout the full range of motion.

The SpaceFlex Shoulder is now available in the U.S., joining G21's hip and knee modular spacer mold systems.

The application for the two-component patellofemoral implant is slated for filing in 2021, followed by launch in 2022.